Carcinogenicity and chronic toxicity of acrolein in rats and mice by two-year inhalation study

Regul Toxicol Pharmacol. 2021 Apr:121:104863. doi: 10.1016/j.yrtph.2021.104863. Epub 2021 Jan 17.


The carcinogenicity and chronic toxicity of acrolein was examined by whole body inhalation to groups of 50 F344/DuCrlCrlj rats and 50 B6D2F1/Crlj mice of both sexes for two years. The concentration of acrolein was 0, 0.1, 0.5 or 2 ppm (v/v) for male and female rats; and 0, 0.1, 0.4 or 1.6 ppm for male and female mice. Two-year administration of acrolein induced the squamous cell carcinomas in nasal cavity which is rare tumor in one male and two female rats. In females, rhabdomyoma in nasal cavity was observed in four rats exposed to 2 ppm. In mice, since the survival rate of male and female of mice control group were lowered than 25% in late of the administration periods due to renal lesion and/or amyloid deposition, the mice study was terminated at 93rd week in males, and was terminated at 99th week in females. The incidences of adenomas in nasal cavity were observed in 16 females and significantly increased only in female mice. Thus, acrolein is carcinogenic in two species, i.e. rats and mice. Additionally, non-neoplastic nasal cavity lesions in rats and mice were observed.

Keywords: Acrolein; Carcinogenicity; Chronic toxicity; Mice; Nasal cavity; Rats.

MeSH terms

  • Acrolein / toxicity*
  • Adenoma / chemically induced*
  • Administration, Inhalation
  • Animals
  • Carcinogenicity Tests
  • Carcinogens / toxicity*
  • Carcinoma, Squamous Cell / chemically induced*
  • Female
  • Male
  • Mice
  • Mice, Inbred Strains
  • Nose Neoplasms / chemically induced*
  • Rats
  • Rats, Inbred F344
  • Rhabdomyoma / chemically induced*


  • Carcinogens
  • Acrolein